Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
09/2005
09/20/2005US6946558 Bipyridinyl derivatives as a highly selective cyclooxygenase-2 inhibitor
09/20/2005US6946491 such as 3-[(4-(2-fluorobenzyloxy)phenyl)-methylthio]propionic acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis
09/20/2005US6946479 for treatment of microbial infections
09/20/2005US6946474 Nitrogen-containing compounds and their use as glycine transport inhibitors
09/20/2005US6946467 Serine protease inhibitors
09/20/2005US6946462 N-monoacylated derivatives of o-phenylenediamines, their analogs and their use as pharmaceutical agents
09/20/2005CA2274946C Diphenylalkyl-tetrahydropyridines, process for their preparation, and pharmaceutical compositions containing them
09/20/2005CA2211668C Substituted heterocyclic compounds, preparation method therefor and pharmaceutical compositions containing the same
09/20/2005CA2153839C 2-(unsubstituted or substituted) (benzyloxy or phenoxy)-4-substituted-6-(meta-substituted phenoxy)pyridine, process for producing the same, and herbicidal composition
09/15/2005WO2005085202A1 Pyridinamide derivative as kinase inhibitors
09/15/2005WO2005085201A1 Novel cyclic compound having 4-pyridylalkylthio group having (un)substituted amino introduced therein
09/15/2005WO2005085200A1 Pyridone derivative
09/15/2005WO2005085199A1 Novel polymorphs of etoricoxib
09/15/2005WO2005085177A2 Biaryl amino acids and their use in dna binding oligomers
09/15/2005WO2005085176A1 π-CONJUGATED AROMATIC RING-CONTAINING COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE
09/15/2005WO2005084368A2 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
09/15/2005WO2005056520A8 Somatostatin receptor subtype 1 (sstr1) active compounds and their use in therapy
09/15/2005WO2005054198A3 Therapeutics use of pyridinium compounds to modulate naadp activity
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049604A3 Antithrombotic aromatic ethers
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203317 Removing the allyl group in a single reaction step with a high reaction rate and a high functional group selectivity without using any additive; cyclopentadienyl ruthenium (II) complex; catalytic dehydration type reaction of alcohols using the ruthenium complex
09/15/2005US20050203289 Functional biopolymer modification reagents and uses thereof
09/15/2005US20050203149 Alkanamide alpha-monohydrazone derivatives, e.g., N-(4-chlorobenzyl)-2-(4-trifluoromethylphenylhydrazono)propionamide, for agricultural and horticultural use, clothing, food and housing-related use, or livestock and pet use
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203093 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
09/15/2005US20050202101 Method and composition for preventing or reducing the symptoms of insulin resistance syndrome
09/15/2005US20050199856 Compound, liquid-crystal composition and optical material
09/15/2005DE4330281B9 Verfahren zur Insektenbekämpfung Method for insect control
09/15/2005CA2557302A1 Pyridinamide derivative as kinase inhibitors
09/15/2005CA2555890A1 Heteroalkyl-substituted biphenyl-4-carboxylic acid arylamide analogues
09/15/2005CA2555712A1 Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
09/14/2005EP1574510A1 Substituted pyridine herbicides
09/14/2005EP1574205A2 Composition comprising a chromophore of azo or tri(hetero)arymethane type
09/14/2005EP1572686A1 Anthranilic acid amide derivatives and their pharmaceutical use
09/14/2005EP1572678A2 Substituted n-phenyl sulfonamide bradykinin antagonists
09/14/2005EP1572670A1 5-substituted-pyrazine or -pyridine glucokinase activators
09/14/2005EP1572663A1 Biphenylcarboxamides
09/14/2005EP1572656A2 Compounds useful as pesticides
09/14/2005EP1572655A2 Novel arylheteroalkylamine derivatives
09/14/2005EP1572654A2 Compounds useful as pesticides
09/14/2005EP1572653A1 Saturated and unsaturated heteroarylcycloalkylmethyl amines as anti-depressants
09/14/2005EP1572652A1 Process for preparing pyridinium fluorochromate (vi)
09/14/2005EP1572651A1 Compounds useful as pesticides
09/14/2005EP1572645A2 Derivatives of succinic and glutaric acids and analogs thereof useful as inhibitors of phex
09/14/2005EP1572625A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents
09/14/2005EP1572612A1 Dihalo-allyloxy-phenol derivatives having pesticidal activity
09/14/2005EP1572112A2 3-(pyridinyl-piperazin-1-yl)-phenylethyl amides as potassium channel openers
09/14/2005EP1572078A2 NOVEL CURCUMINOID-FACTOR VIIa CONSTRUCTS AS SUPPRESSORS OF TUMOR GROWTH AND ANGIOGENESIS
09/14/2005EP1572068A2 Arylheteroalkalylamine derivatives and their use as inhibitors of nitric oxide synthase
09/14/2005EP1409440A4 A method to inhibit ethylene responses in plants
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1283825B1 N-substituted peptidyl nitriles as cysteine cathepsin inhibitors
09/14/2005EP1171127B1 Pharmaceutical compositions containing pyridine or pyrimidine derivatives for inhibition of cytokine production and secretion
09/14/2005EP1082307B1 Processes and intermediates for preparing 2-substituted piperidine stereoisomers
09/14/2005CN1669361A Organic light emitting devices having carrier blocking layers comprising metal complexes
09/14/2005CN1668730A Use of metal complex compounds as oxidation catalysts
09/14/2005CN1668703A Charge transport compositions on the basis of triarylmethanes and their use in electronic devices
09/14/2005CN1668616A Charge transport compositions comprising fluorizated quinazoline derivatives
09/14/2005CN1668604A Novel anthracene derivatives and the use thereof as a medicament
09/14/2005CN1668596A Process for the preparation of modification I of N-(1-methylethylaminocarbonyl)-4-(3-methylphenylamino)-3-pyridinesulfonamide
09/14/2005CN1668595A Method of forming a carbon-carbon or carbon-heteroatom linkage
09/14/2005CN1668594A New derivatives of pyridilethanol (phenylethyl) amines as cholesterol biosynthesis inhibitors, procedures of their preparation and pharmaceutical preparations which they contain
09/14/2005CN1668574A Process for the preparation of phenylalanine enamide derivatives
09/14/2005CN1668302A Sulphonylpiperidine derivatives containing an alkenyl or alkynly moiety for use as matrix metalloproteinase inhibitors
09/14/2005CN1668195A Malononitrile compounds and their uses
09/14/2005CN1218942C Antifibrosis pyridinone compound and its preparing process
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218919C Fluorene derivatives and their application
09/13/2005US6943257 Low cost, minimizing environmental pollution, halogenation in presence of halodimethylsulfonium halide prepared in situ from halohydric acid and dimethylsulfoxide, as activated nucleophilic agent, one-pot process, bromination
09/13/2005US6943254 Reaction of the diazonium salt of an aminopyridine or aminobenzene in which the benzene ring bears one or more electron-withdrawing groups with a mixture of thionyl chloride in water, in the presence of an electron transfer-catalyst
09/13/2005US6943196 NF-κB inhibitor comprising phenylmethyl benzoquinone as the active ingredient
09/13/2005US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal
09/13/2005US6943179 Biurethane derivatives
09/13/2005US6943170 N-cycloalkylglycines as HIV protease inhibitors
09/13/2005US6943168 Calcium channel inhibitors comprising benzhydril spaced from piperazine
09/13/2005CA2216099C Alpha-substituted pyrimidine-thioalkyl and alkylether compounds as inhibitors of viral reverse transcriptase
09/10/2005CA2500136A1 Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers
09/10/2005CA2460432A1 Process for the preparation of torsemide and related intermediates
09/09/2005WO2005082903A1 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082853A1 Semicarbazide derivatives as kinase inhibitors
09/09/2005WO2005082820A1 Method for preparation of a fluoroaromatic compound from an aminoaromatic amine compound.
09/09/2005WO2005082367A1 Kinase inhibitors
09/09/2005WO2005058884A3 Cyclopropane compounds and pharmaceutical use thereof
09/09/2005WO2005046603A3 Pyridine compounds
09/09/2005WO2005032493A3 Amide compounds as ion channel ligands and uses thereof
09/09/2005WO2005028442A3 2-pyridinone derivatives, having hiv inhibiting properties
09/09/2005CA2557359A1 Semicarbazide derivatives as kinase inhibitors
09/09/2005CA2555724A1 2-(pyridin-3-ylamino)-pyrido[2,3-d]pyrimidin-7-ones
09/09/2005CA2543861A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005CA2543859A1 Novel pyridine derivative and pyrimidine derivative (1)
09/08/2005US20050197501 Reacting calcium hydroxide with an ester derivative or protected ester derivative of the statin; rosuvastatin, pitavastatin and atorvastatin, simvastatin and lovastatin
09/08/2005US20050197364 Amide compounds as ion channel ligands and uses thereof
09/08/2005US20050197320 Phosphonate and sulfide substituted imidazole compounds; antihuman immunodeficiency viral agents
09/08/2005US20050196671 Ionic liquids of heterocyclic amines
09/08/2005DE102004009238A1 New aryl amide compounds are kinase inhibitors useful for the treatment and/or prophylaxis of e.g. tumors, psoriasis, rheumatoid arthritis, contact dermatitis, inflammations, endometriosis, scar and benign prostatic hyperplasia
09/07/2005EP1571150A1 Process for the preparation of tryptase inhibitors
09/07/2005EP1571146A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
1 ... 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 ... 633